Bal Pharma Limited (NSE:BALPHARMA)
India · Delayed Price · Currency is INR 83.51
+1.48 (1.80%)
May 25, 2026, 9:49 AM IST
Bal Pharma Market Cap
Bal Pharma has a market cap or net worth of 1.3 billion as of May 22, 2026. Its market cap has decreased by -21.91% in one year.
Market Cap
1.30B
Enterprise Value
2.76B
Revenue
3.09B
Ranking
n/a
PE Ratio
16.06
Stock Price
83.51
Market Cap Chart
Since December 20, 2004, Bal Pharma's market cap has increased from 559.95M to 1.30B, an increase of 133.04%. That is a compound annual growth rate of 4.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 1.30B | 11.89% |
| Dec 31, 2025 | 1.17B | -39.96% |
| Dec 31, 2024 | 1.94B | 23.18% |
| Dec 29, 2023 | 1.58B | 10.20% |
| Dec 30, 2022 | 1.43B | -8.67% |
| Dec 31, 2021 | 1.57B | 96.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sigachi Industries | 7.79B |
| Valiant Laboratories | 4.13B |
| Bafna Pharmaceuticals | 3.21B |
| Nectar Lifesciences | 2.37B |
| Brooks Laboratories | 1.51B |
| Alpa Laboratories | 1.46B |
| Balaxi Pharmaceuticals | 1.38B |
| Par Drugs and Chemicals | 1.02B |